• How to Register
    • How to Register (Canada)
    • How to Register (UK)
  • The ADT Book
    • About the ADT Book
    • About the Authors
    • Who Is The ADT Book For?
    • Where Can I Buy The ADT Book?
    • Endorsements for The ADT Book
  • Hear from program participants
  • Patient Videos
    • Introduction
    • Physical Side Effects
    • Psychological Well-Being, Sexuality, and Intimacy
    • Making Successful Lifestyle Changes
  • Reference Tables from the ADT Book
    • Main Drugs for Prostate Cancer
    • Nutrition Information Tables
    • Medications for Hot Flashes
  • Resources
    • Physical Activity & Other Resources
  • Posts on Recent ADT Literature
  • Contact
  • Menu

Life on ADT

  • How to Register
    • How to Register (Canada)
    • How to Register (UK)
  • The ADT Book
    • About the ADT Book
    • About the Authors
    • Who Is The ADT Book For?
    • Where Can I Buy The ADT Book?
    • Endorsements for The ADT Book
  • Hear from program participants
  • Patient Videos
    • Introduction
    • Physical Side Effects
    • Psychological Well-Being, Sexuality, and Intimacy
    • Making Successful Lifestyle Changes
  • Reference Tables from the ADT Book
    • Main Drugs for Prostate Cancer
    • Nutrition Information Tables
    • Medications for Hot Flashes
  • Resources
    • Physical Activity & Other Resources
  • Posts on Recent ADT Literature
  • Contact

Is the long term burden of ADT plus radiotherapy worse than ADT alone?

November 20, 2015

Key sentence from the paper: “The addition of radiotherapy to ADT for patients with locally advanced prostate cancer significantly improved overall survival and had only modest and transient negative impact on relevant domains of health-related quality of life [outcomes].” 

Read More

Does prostate cancer progress faster for advanced patients with diabetes on ADT?

November 17, 2015

Key sentence from the paper: “Diabetes mellitus may have a detrimental effect on progression of advanced prostate cancer, particularly in those patients with radiographic evidence of metastases.” 

Read More

With over-prescribing ADT in the US, are all patients treated equally?

November 12, 2015

Key sentence from the paper: “Increased age, greater comorbidity, being in a racial/ethnic minority, high primary care utilization in the prior year and receiving a radiation oncology consultation before treatment were associated with increased odds of gonadotropin releasing hormone agonist overuse.” 

Read More

Ethnic difference may exist in the efficacy and adverse effects of ADT

November 09, 2015

Key sentence from the paper: “In terms of adverse effects, including bone loss, cardiovascular risk, and other factors, ADT appeared to be better tolerated in Japanese than Western populations.” 

Read More

Yet again, ADT is linked to metabolic syndrome and diabetes

November 05, 2015

Key sentence from the paper: “The results [of this study] suggest a 75% increased risk of metabolic syndrome and a 36% increased risk of diabetes following ADT for men with prostate cancer.” 

Read More

Does a healthy lifestyle help for patients already on ADT?

November 03, 2015

Key sentence from the paper: “A 6-month diet and physical activity intervention can minimize the adverse body composition changes associated with ADT.” 

Read More

When is it beneficial to add chemotherapy to ADT plus radiotherapy?

October 30, 2015

Key sentence from the paper: “[This study] found no statistically significant difference in the outcome of overall survival, biochemical failure, local progression, distant metastasis or disease-free survival with the addition of chemotherapy using oral etoposide to a regimen of 2 years of androgen suppression + radiation therapy.”

Read More

Are there certain populations that benefit from ADT as a primary treatment?

October 27, 2015

Key sentence from the paper: “[T]here is no increase in the mortality of men treated with [primary androgen deprivation therapy].

Read More

Do the newer agents for ADT add to the cardiovascular risk of the LHRH drugs?

October 23, 2015

Key sentence from the paper: “[O]ur analysis reported a significant increase in cardiac events and hypertension in [metastatic castrate resistant prostate cancer] patients treated with new hormonal therapies.” 

Read More

Are there racial differences in the risk of fractures for patients on ADT?

October 19, 2015

Key sentence from the paper: “ADT with GnRH agonists or orchiectomy increases the risk of fracture in Chinese patients with prostate cancer. However, the magnitude of the increase in risk is seemingly not as large as that in Western populations.”

Read More
Prev / Next

Life on ADT - Blog

The Life on ADT Blog, written by Richard Wassersug and project assistant, Hannah Stremick, reviews and summarizes recent findings in the medical and psychological literature related to ADT. The blog is a place where you can keep up to date on advances in ADT and ways to manage ADT side effects. To receive an email notification when new blog posts are published, please enter your details below.